{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T06:59:38Z","timestamp":1700549978598},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s11864-001-0037-1","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T20:43:58Z","timestamp":1183581838000},"page":"237-244","source":"Crossref","is-referenced-by-count":13,"title":["Infectious complications in chronic lymphoid malignancy"],"prefix":"10.1007","volume":"2","author":[{"given":"Gerlinde","family":"Egerer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.1994.tb05002.x","volume":"88","author":"H Chapel","year":"1994","unstructured":"Chapel H, Dicato M, Gamm H, et al.: Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimens. Br J Haematol 1994, 88:209\u2013212.","journal-title":"Br J Haematol"},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0609.1990.tb00345.x","volume":"44","author":"A Apostopoulos","year":"1990","unstructured":"Apostopoulos A, Simeonidis A, Zoumbos N: Prognostic significance of immune function parameters in patients with chronic lymphocytic leukemia. Eur J Haematol 1990, 44:39\u201344.","journal-title":"Eur J Haematol"},{"key":"37_CR3","first-page":"147","volume-title":"Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments","author":"G Dighiero","year":"1993","unstructured":"Dighiero G: Hypogammaglobulinemia and disordered immunity in CLL. In Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments. Edited by Cheson BD. New York: Dekker; 1993:147\u2013166."},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0609.1992.tb01805.x","volume":"48","author":"M It\u00e4l\u00e4","year":"1992","unstructured":"It\u00e4l\u00e4 M, Helenius H, Nikoskelaien J, et al.: Infections and serum IgG levels in patients with chronic lymphocytic leukemia. Eur J Haematol 1992, 48:266\u2013270.","journal-title":"Eur J Haematol"},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00005792-198409000-00001","volume":"63","author":"SC Ross","year":"1984","unstructured":"Ross SC, Densen P: Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in immune deficiency. Medicine (Baltimore) 1984, 63:243\u2013273.","journal-title":"Medicine (Baltimore)"},{"key":"37_CR6","first-page":"98","volume":"25","author":"VA Morrison","year":"1998","unstructured":"Morrison VA: The infectious complications of chronic lymphocytic leukemia. Semin Oncol 1998, 25:98\u2013106. A comprehensive and well-summarized review article.","journal-title":"Semin Oncol"},{"key":"37_CR7","first-page":"250","volume":"2","author":"PJ Morris","year":"1986","unstructured":"Morris PJ, Cooper IA, Madigan JP: Splenectomy for hematological cytopenias in patients with malignant lymphomas. Lancet 1986, 2:250\u2013253.","journal-title":"Lancet"},{"key":"37_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/10428199409056283","volume":"13","author":"S Molica","year":"1994","unstructured":"Molica S: Infections in chronic lymphocytic leukemia: risk factors and impact on survival and treatment. Leuk Lymphoma 1994, 13:203\u2013214.","journal-title":"Leuk Lymphoma"},{"key":"37_CR9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/1097-0142(19830415)51:8<1546::AID-CNCR2820510832>3.0.CO;2-A","volume":"51","author":"M Chu","year":"1983","unstructured":"Chu M, Brown AE, Blevins A, et al.: Severe pneumococcal infection in patients with neoplastic disease. Cancer 1983, 51:1546\u20131550.","journal-title":"Cancer"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/0003-4819-129-7-199810010-00010","volume":"129","author":"EJ Anaissie","year":"1998","unstructured":"Anaissie EJ, Kontoyannis D, O\u2019Brien S, et al.: Infections in patients with chronic lymphocytic leukemia treated with Fludarabine. Ann Intern Med 1998, 129:559\u2013566.","journal-title":"Ann Intern Med"},{"key":"37_CR11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","volume":"82","author":"S O\u2019Brien","year":"1993","unstructured":"O\u2019Brien S, Kantarjian H, Beran M, et al.: Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 1993, 82:1695\u20131700.","journal-title":"Blood"},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198810063191403","volume":"319","author":"Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia","year":"1988","unstructured":"Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia: Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. N Engl J Med 1988, 319:902\u2013907.","journal-title":"N Engl J Med"},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199107113250202","volume":"325","author":"JC Weeks","year":"1991","unstructured":"Weeks JC, Tierney MR, Weinstein MC: Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med 1991, 325:81\u201386.","journal-title":"N Engl J Med"},{"key":"37_CR14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/sj.leu.2400816","volume":"11","author":"S O\u2019Brien","year":"1997","unstructured":"O\u2019Brien S, Kantarjian H, Beran M, et al.: Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia. Leukemia 1997, 11:1631\u20131635. Patients treated with purine analogues and G-CSF were compared with a historical control group.","journal-title":"Leukemia"},{"key":"37_CR15","first-page":"205a","volume":"72","author":"DR Jacobson","year":"1988","unstructured":"Jacobson DR, Ballard HS, Silber R, et al.: Antibody response in pneumococcal immunization in patients with chronic lymphocytic leukemia. Blood 1988, 72(suppl):205a.","journal-title":"Blood"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000007134","volume":"44","author":"M Karthaus","year":"1998","unstructured":"Karthaus M, Wolf HH, Kampfe D, et al.: Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia. Chemotherapy 1998, 44:343\u2013354.","journal-title":"Chemotherapy"},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","volume":"328","author":"PA Pizzo","year":"1993","unstructured":"Pizzo PA: Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993, 328:1323\u20131232.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-001-0037-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0037-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T01:32:34Z","timestamp":1587691954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-001-0037-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s11864-001-0037-1","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}